Amenamevir

DB11701InvestigationalSmall molecule

Amenamevir has been used in trials studying the treatment of Herpes Zoster, Herpes Simplex, Herpes Genitalis, and Safety of Amenamevir.

Chemical structure of Amenamevir
Formula / weight
C24H26N4O5S · 482.56 g/mol (avg)
Code names
ASP-2151

Resolves to

Compound
UNII94X46KW4AECAS841301-32-4PubChem11397521
Clinical / RWD
ATCJ05AX26
Structure
InChIKeyMNHNIVNAFBSLLX-UHFFFAOYSA-NSMILESCC1=CC=CC(C)=C1N(CC(=O)NC1=CC=C(C=C1)C1=NOC=N1)C(=O)C1CCS(=O)(=O)CC1

What you can answer from here — as of July 07, 2026

14Drug interactionsStructured to mechanism, not free text
Sign in
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 12 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Amenamevir, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In